We have located links that may give you full text access.
Clinical Trial
English Abstract
Journal Article
Randomized Controlled Trial
[Effect of eleutherosides on ventricular late potential with coronary heart disease and myocarditis].
The article studied the curative effect of eleutherosides in patients with coronary heart disease and myocarditis whose ventricular late potential (VLP) were positive by means of control study. All the 57 patients were randomly divided into two groups. The 31 patients were classified as therapeutic group including male 25 and female 6, the ages ranged from 18-65 years old (mean 51.8). The other 26 patients were defined as control group including male 21 and female 5, the ages ranged from 16-63 years old (mean 50.8). The therapeutic group was treated with injectio acanthopanacis senticosi 40 ml dissolved in 5% dextrose injection 300 ml by intravenous drop once daily. The control group was given insulin injection 12 u and potassium chloride injection 1 g dissolved in 10% dextrose injection 500 ml also by intravenous drop once daily. Both courses of treatment were 15 days. The rates of changing positive VLP into negative in two groups were 74.29% vs 34.6% (P less than 0.005). The results proved that eleutherosides is an effective drug to patients with positive VLP.
Full text links
Related Resources
Trending Papers
Obesity pharmacotherapy in older adults: a narrative review of evidence.International Journal of Obesity 2024 May 7
SGLT2 Inhibitors in Kidney Diseases-A Narrative Review.International Journal of Molecular Sciences 2024 May 2
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app